Pituitary Adenylyl Cyclase-activating Peptide (PACAP) Deficient Mice

Tech ID: 20535 / UC Case 2001-466-0

Background

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid peptide that was first isolated from ovine hypothalamic extracts. It has been previously observed that light information reaches the suprachiasmatic nucleus through a population of retinal ganglion cells that contain PACAP, however the involvement of PACAP and its receptor is not well studied. In order to study the role of PACAP in vivo, a new mouse model was developed in which the gene encoding for PACAP was disrupted by homologous recombination.

Innovation

PACAP deficient mice exhibit significant impairment in the magnitude of the response to brief light exposures. Researches observed about a 50% reduction in the magnitude of both light-induced phase delays and advances of the circadian system in the PACAP deficient mice. Overall, loss of PACAP produced selective deficits in the light response of the circadian system.

Applications

  • Research tool for the study of circadian rhythms
  • Development of drugs that overcome the phenotype observed in the PACAP deficient mice
  • To study additional biological effects PACAP may have an effect on other areas of the body.

Related Materials

Other Information

To complete a Ready-to-Sign Agreement for this case, please view this document. [PDF]

Contact

Inventors

  • Waschek, James A.

Other Information

Keywords

research tools mouse models drug development

Categorized As

UCLA Technology Development Group
10889 Wilshire Blvd., Suite 920,Los Angeles,CA 90095
tdg.ucla.edu
Tel: 310.794.0558 | Fax: 310.794.0638 | ncd@tdg.ucla.edu